ATH 33.3% 0.4¢ alterity therapeutics limited

Forebrain atrophy in early AD, by Masters et al, page-8

  1. 905 Posts.
    lightbulb Created with Sketch. 83
    Sorry for the split conversation boxes, couldnt add the biomuse screen shot to original post.

    Anyways, as read, normal brain mass loss is 5% a decade after the age of 40yrs of age. The biomuse study found MSA pts have a mass reduction of 3-5% at 6 and 12 months. So, again, if they can prove ATH434 can show positive signs of rapidly reducing the speed of brain loss, it may also slow other neurodegenerate brain loss in other diseases such as AD and FA.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $5.491K 1.520M

Buyers (Bids)

No. Vol. Price($)
39 50987030 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126437200 27
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.